Definiens Forms Strategic Partnership with Tessella
News Jan 16, 2009
Definiens has formed a systems integration partnership with Tessella, the information technology and consulting services company selected by R&D, science and engineering leaders for business-critical assignments.
Under the terms of the agreement, Definiens will train Tessella consultants to deploy and integrate Definiens image analysis technology into the IT infrastructures of large pharmaceutical and biotechnology companies.
Definiens’ image analysis software is built on the company’s proprietary Definiens Cognition Network Technology®, which emulates human cognitive processes to extract intelligence from images.
Tessella’s consultants will receive advanced training in Definiens XD, the company’s new platform for multidimensional image analysis. Tessella’s experts will develop new rule sets and applications for the seamless integration of Definiens technology across their clients’ IT infrastructure, and will provide on-site support and troubleshooting services. Tessella will also independently market software incorporating Definiens technology.
“Tessella aims to provide the best solution to our clients’ complex problems,” said Lawrence Hopkins, Associate Director at Tessella. “Definiens is clearly leading the image analysis field and we are delighted to be able to bring our clients two “best of breeds” in one solution – Definiens’ leading edge, innovative image analysis software and Tessella’s understanding of the underlying science being carried out by our clients and our excellent project delivery reputation.”
Tessella’s extensive network of consultants will accelerate the enterprise-wide integration of Definiens technology, as well as providing embedded support services to Definiens’ existing and future customers.
“Partnering with Tessella will enable our technology to be seamlessly implemented across large-scale enterprises,” said Manfred Voglmaier, Vice President of Business Development for Definiens’ Life Science division. “The partnership will expand our access to new markets and allow us to pursue larger clients for our premiere imaging analysis technology.”
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE
BOC Sciences Continues to Enlarge Its Publication Collection Using BOC Sciences ProductsNews
BOC Sciences continues to add more publication items that used BOC Sciences products in their researches to its already existing collection.READ MORE
Sciformix Corporation Collaborates with Oracle Health SciencesNews
New collaboration enables faster and more informed drug safety decisions.READ MORE